INLIF LIMITED (INLF), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced the pricing of its initial public offering (the “Offering”) of 2,000,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on January 2, 2025 under the ticker symbol “INLF.”
The Company expects to receive aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 ordinary shares at the public offering price, less underwriting discounts. The Offering is expected to close on or about January 3, 2025, subject to the satisfaction of customary closing conditions.
Proceeds from the Offering will be used for (i) the construction of a 5G digital intelligent equipment production base; (ii) establishing 24 local marketing and service offices within the PRC; (iii) the construction of an industrial robot and automation application technology research and development center; and (iv) working capital.
The Offering is being conducted on a firm commitment basis. AC Sunshine Securities LLC acted as underwriter for the Offering (the “Underwriter”). Hunter Taubman Fischer & Li LLC is acting as U.S. securities counsel to the Company, and iTKG Law LLC is acting as U.S. counsel to the Underwriter in connection with the Offering.
A registration statement on Form F-1 relating to the Offering was filed with the U.S. Securities and Exchange Commission (the “SEC”) (File Number: 333-279569) and was declared effective by the SEC on December 20, 2024. The Offering is being made only by means of a prospectus, forming a part of the registration statement. Copies of the prospectus relating to the Offering may be obtained from AC Sunshine Securities LLC, Attn: 200 E. Robinson Street, Suite 295, Orlando, FL 32801, or by email at prospectus@acsunshine.com, or by calling +1(689)-867-6218. In addition, copies of the prospectus relating to the Offering may be obtained via the SEC’s website at www.sec.gov.
Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release does not constitute an offer to sell, or the solicitation of an offer to buy any of the Company’s securities, nor shall there be any offer, solicitation or sale of any of the Company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
Source link
